|
⚲
|
| Keyboard |
| Kruger Kurt H
✚
|
|
|---|---|
| CIK # | 0001375881 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001375881] | |
| 4 | [0001375881] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Ritter Pharmaceuticals Inc | |
| Kruger Kurt H | |
| Emmaus Life Sciences Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Ritter Pharmaceuticals Inc QLGN
Stock Option (Right to Buy) · derivative
|
2022-07-11 | Grant | 40,000 | $0.00 | |
|
Ritter Pharmaceuticals Inc QLGN
Common Stock
|
2021-08-19 | Buy | 4,000 | $1.22 | 4,880 |
|
Ritter Pharmaceuticals Inc QLGN
Common Stock
|
2021-08-19 | Buy | 4,000 | $1.23 | 4,920 |
|
Ritter Pharmaceuticals Inc QLGN
Common Stock
|
2020-12-29 | Buy | 4,000 | $2.94 | 11,760 |
|
Ritter Pharmaceuticals Inc QLGN
Common Stock
|
2020-11-23 | Buy | 4,600 | $3.46 | 15,916 |
|
Ritter Pharmaceuticals Inc QLGN
Common Stock
|
2020-11-20 | Buy | 1,400 | $3.55 | 4,970 |
|
Ritter Pharmaceuticals Inc QLGN
Stock Option (Right to Buy) · derivative
|
2020-06-06 | Grant | 50,000 | $0.00 | |
|
Ritter Pharmaceuticals Inc QLGN
Warrant (Right to Buy) · derivative
|
2020-05-22 | Other | 8,857 | ||
|
Emmaus Life Sciences Inc NONE
Options · derivative
|
2018-08-16 | Grant | 50,000 | $0.00 |